Skip to main content
Fig. 3 | International Journal of Retina and Vitreous

Fig. 3

From: Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

Fig. 3

A 58-years-old man with chronic central serous chorioretinopathy in the left eye. He had focal laser therapy 4 months before starting eplerenone therapy. Eplerenone treatment decreased subretinal fluid, choroidal thickness, and central macular thickness after 4 weeks. ac Baseline scans before start of eplerenone. d, e Scans from 4 weeks after eplerenone treatment. a, d Infrared scans. b, e 5-line raster enhanced depth-optical coherence tomography (EDI-OCT) from the fovea. c, f Central macular thickness calculated automatically by the software

Back to article page